Transforming T-Cell Receptor Cell & Biologic Approaches

Leveraging Novel Targets, Advanced Engineering & Clinical Strategies to Expand Patient Populations for In-Market Success of TCR-Based Cell & Biologic Therapies

The past few years for the TCR community have been dynamic. Approvals have signalled a viable path to commercialization, while a wave of company closures highlight the deep-rooted challenges in the current development processes. The message is clear: success is not guaranteed at approval. Addressing manufacturing costs, durability and long-term commercial viability is now mission critical for developers of TCR-based cell and biologic therapies.

Spanning the full therapeutic landscape, including TCR-T, TCR mimetics, TCR-TCEs and TCR bispecifics, the 7th TCR-Based Therapies Summit cuts through the noise to focus exclusively on the challenges most acutely impacting the TCR field today. Connect with and hear directly from senior leaders driving progress at the forefront of the field, including C-suite leaders at Immunocore, Immatics, T-knife Therapeutics, Anocca, Zelluna Immunotherapy, Enara Bio, Marengo Therapeutics, and 3T Biosciences.

With the foundations now in place, join us in empowering the community to shape a more durable, scalable, and commercially robust future for TCR-based therapies.

 

We heard great updates from the field of TCR-based therapies. I was able to participate in excellent discussions and interactions thanks to the chairmans

Chief Scientific Officer, CDR-Life, 2024 Speaker

cdr- life logo

It was a highly focused meeting with a representative from almost all of the top biotech companies in the field

Associate Director, Immatics, 2024 Attendee

immatics logo

This is the only conference focusing on TCR-based therapeutics. The intimate size of the meeting permitted for frequent discussions with other participants

Head, Translational Medicine, Engimmune Therapeutics, 2025 Attendee

engimmune logo

Delve into the Complete Event Program

Find Inside...

  • Interactive Workshops on Next-Generation TCR Targets & Novel Engineering Strategies
  • Unrivalled Networking Opportunities with Industry-Leading TCR Developers
  • Brand-New Data Presentations Led by Top Biopharma Professionals
  • Insight into the Only Meeting Dedicated to TCR-Based Therapy Advancement
Brochure cover for 7th TCR-Based Therapies Summit 2026

What To Expect

55%

Chief/VP-Level Speaker Faculty

20+

World-Class Speakers

6+

Hours of Structured Networking

5

Talks Showcasing Brand-New Data

1

Forum Dedicated to TCR-Based Therapies

Official Partners

Brochure cover for 7th TCR-Based Therapies Summit 2026
Quick Download

Attending Companies Include

Regeneron Company Logo
Immunocore sponsor logo
Enara Bio Logo
Zelluna Immunotherapy Company Logo
Anocca company logo
T-Cypher Bio logo
Crossbow Therapeutics logo
Marengo Therapeutics logo
Immatics Company Logo
networking photo
Discover the Agenda

See the agenda delivering the latest breakthroughs and real-world insights on TCR-T, TCR mimetics, TCR-TCEs, and TCR bispecifics.

networking photo
Partner With the Future

Position your brand at the center of the TCR ecosystem by partnering with leading developers shaping the future of TCR-based therapies.

networking photo
Collaborate With TCR Experts

Connect with senior leaders across biopharma and academia during high-value networking sessions and the scientific poster session.